Kawasaki disease (KD) arises due to the disorder of the inflammation response and faulty immune regulation. Interleukin-27 (IL-27) is a novel cytokine with both pro-inflammatory and anti-inflammatory effects. This study investigated the relationship between serum levels of IL-27, Interleukin-17A (IL-17A), Interleukin-10 (IL-10), Interleukin-6 (IL-6), Interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and coronary artery lesions (CALs) in patients with KD. We obtained blood samples from 81 children with KD before intravenous immunoglobulin (IVIG) therapy. Levels of IL-27, IL-17A, IL-10, IL-6, IL-1β and TNF-α were measured in 251 cases, including 4 groups: the normal control group, NC (n = 90), febrile control, FC (n = 80), KD without coronary arteries (n = 41) and KD with coronary arterial lesions (n = 40). White blood cells counts (WBC), red blood cells counts (RBC), hemoglobin, C-reactive protein (CRP), erythrocyte sedimentation rate and procalcitonin (PCT) were tested in all subjects. Levels of IL-27, IL-10, IL-17A, IL-6, IL-1β and TNF-α were significantly elevated, and RBC and hemoglobin significantly decreased in the group of KD group compared with febrile and control groups. IL-27, IL-6, IL-1β and TNF-α serum levels are even higher in KD children with CALs. There was positive relationship between serum levels of IL-27 and WBC, CRP, PCT, IL-10, IL-17A, IL-6 and TNF-α in children with KD. The up-regulation of IL-27 may be closely linked to up-regulation of systemic pro-inflammatory markers in acute KD. Morover, IL-27 may be involved in the development of CALs in acute KD.
This is a preview of subscription content, log in to check access.
This work was supported by National Natural Science Foundation of China under Grant: No. 81270412 and National Natural Science Foundation of China under Grant: No. 81500273.
Compliance with ethical standards
Conflict of interest
All authors have no actual or potential conflicts of interest with other people or organizations with 3 years of initiating the work presented here.
The study protocol was approved by the Ethics Committee of Children’s Hospital of Chongqing Medicine University, and written informed consent forms were obtained from the parents of all subjects.
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observations of 50 cases. Jpn J Allerg. 1967;16:178–222.Google Scholar
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708–33.CrossRefPubMedGoogle Scholar
Settin A, Ismail A, El-Magd MA, et al. Gene polymorphisms of TNF-alpha-308 (G/A), IL-10 (-1082) (G/A), IL-6 (-174) (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus. Autoimmunity. 2009;42:50–5.CrossRefPubMedGoogle Scholar
Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148:32–46.CrossRefPubMedPubMedCentralGoogle Scholar
Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodi-meric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity. 2002;16:779–90.CrossRefPubMedGoogle Scholar
Boulay JL, O’Shea JJ, Paul WE, et al. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity. 2003;19(2):159–63.CrossRefPubMedGoogle Scholar
Lin TT, Lu J, Qi CY, et al. Elevated serum level of IL-27 and VEGF in patients with ankylosing spondylitis and associate with disease activity. Clin Exp Med. 2015;15(2):227–31.CrossRefPubMedGoogle Scholar
Seita J, Asakawa M, Ooehara J, et al. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood. 2008;111(4):1903–12.CrossRefPubMedGoogle Scholar
Wong Hector R, Cvijanovich Natalie Z, Hall Mark, et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care. 2012;16:R213.CrossRefPubMedPubMedCentralGoogle Scholar
JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008). Circ J. 2010;74:1989–2020.CrossRefGoogle Scholar
Japan Kawasaki Disease Research Committee. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health and Welfare; 1984.Google Scholar
Liu R, He B, Gao F, et al. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease. Transl Res. 2012;160:131–6.CrossRefPubMedGoogle Scholar
Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol. 1997;112:152–6.CrossRefPubMedGoogle Scholar
Guo MM-H, Tseng W-N, Ko C-H, et al. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy. 2015;70:310–8.CrossRefPubMedGoogle Scholar
Maddur MS, Sharma M, et al. Inhibitory Effect of IVIG on IL-17 production by Th17 Cells is Independent of Anti-IL-17 antibodies in the Immunoglobulin Preparations. J Clin Immunol. 2013;33:S62–6.CrossRefPubMedGoogle Scholar
Maddura Mohan S, Kaveri Srini V, Bayry Jagadeesh. Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmun Rev. 2011;10:809–10.CrossRefGoogle Scholar
Maddur MS, Hegde P, et al. Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. J Allergy Clin Immunol. 2011;127(3):823–30.CrossRefPubMedGoogle Scholar
Rasouli Manoochehr, Heidarib Behzad, Kalani Mehdi, et al. Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease. Immunol Lett. 2014;162:269–75.CrossRefPubMedGoogle Scholar
Yoshida H, Nakaya M, Miyazaki Y. Interleukin 27: a double-edged sword for offense and defense. J Leukoc Biol. 2009;86:1295–303.CrossRefPubMedGoogle Scholar
Wirtz S, Tubbe I, Galle PR, et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med. 2006;203:1875–81.CrossRefPubMedPubMedCentralGoogle Scholar
Niedbala W, Cai B, Wei X, et al. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis. 2008;67:1474–9.CrossRefPubMedGoogle Scholar
Ma Ming-Chieh, Bao-Wei WangTzu-Pei Yeh, et al. Interleukin-27, a novel cytokine induced by ischemia–reperfusion injury in rat hearts, mediatescardioprotective effectsvia the gp130/STAT3 pathway. Basic Res Cardiol. 2015;110:22.CrossRefPubMedGoogle Scholar
Yoshimoto T, Yoshimoto T, Yasuda K, et al. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol. 2007;179(7):4415–23.CrossRefPubMedGoogle Scholar
Lai X, Wang H, Cao J, et al. Circulating IL-27 is elevated in rheumatoid arthritis patients. Molecules. 2016;21(11):1565.CrossRefGoogle Scholar
Stumhofer JS, Laurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 2006;7:937–45.CrossRefPubMedGoogle Scholar
Wang H, Meng R, Li Z, et al. IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3. Immunol Lett. 2011;136:21–8.CrossRefPubMedGoogle Scholar
Kobayashi N, Mori M, Kobayashi Y, et al. Intravenous gamma-globulin therapy improves hypercytokinemia in the acute phase of Kawasaki disease. Mod Rheumatol. 2004;14:447–52.CrossRefPubMedGoogle Scholar
Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol. 1997;79:469–83.CrossRefPubMedGoogle Scholar
CromeSQ WangAY. LevingsMK. Translationalmini-reviewseries on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol. 2010;159:109–19.CrossRefGoogle Scholar
Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL- 17 via C-X-C chemokine release in the airways. J Immunol. 1999;162:2347–52.PubMedGoogle Scholar
Afzali B, Mitchell P, Lechler RI, et al. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol. 2010;159:120–30.CrossRefPubMedPubMedCentralGoogle Scholar
Volin MV, Shahrara S. Role of TH-17 cells in rheumatic and other autoimmune diseases. Rheumatology (Sunnyvale). 2011. doi:10.4172/2161-1149.1000104.
Tang SC, Fan XH, Pan QM, et al. Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis. J Neurol Sci. 2015;348(1–2):174–80.CrossRefPubMedGoogle Scholar
Yoshikawa H, Nomura Y, Masuda K, et al. Serum procalcitonin value is useful for predicting severity of Kawasaki disease. Pediatr Infect Dis J. 2012;31(5):523–5.CrossRefPubMedGoogle Scholar
Pietraforte Donatella, Gambardella Lucrezia, Marchesi Alessandra, et al. Red blood cells as bioindicators of cardiovascular risk in Kawasaki disease: a case report. Int J Cardiol. 2015;181:311–3.CrossRefPubMedGoogle Scholar
Straface E, Gambardella L, Metere A, et al. Oxidative stress and defective platelet apoptosis in naïve patient with Kawasaki disease. Biochem Biophys Res Commun. 2010;392:426–30.CrossRefPubMedGoogle Scholar
Galeotti C, Kaveri SV, Cimaz R, et al. Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease. Drug Discov Today. 2016;21(11):1850–7.CrossRefPubMedGoogle Scholar